Source: Annual Congress 2001 - OSA and other sleep related breathing disorders: epidemiology, diagnosis, treatment
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
T. E. Wessendorf, Y. M. Wang, A. F. Thilmann, N. Konietzko, H. Teschler (Essen, Germany). OSA and control of hypertension in stroke. Eur Respir J 2001; 16: Suppl. 31, 2360

Member's Comments

No comment yet.

Related content which might interest you: OSA and stroke Source: Sleep and Breathing Conference 2021 Year: 2021 SDB and stroke Source: ERS Conference Year: 2015 SAHS and stroke. CPAP compliance and new stroke events Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2012; 39: 906-912 Year: 2012 Prevalence of sleep apnea in ischaemic stroke Source: Eur Respir J 2006; 28: Suppl. 50, 197s Year: 2006 The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Importance of controlled blood pressure values in a population with obstructive sleep apnea syndrome (OSA) and arterial hypertension (HT) Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Eur Respir J 2013; 41: 523-538 Year: 2013 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007 Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Treating obstructive sleep apnoea to improve control of hypertension Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights Year: 2014 Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Diastolic diurnal hypertension is underestimated in patients with unknown hypertension at time of sleep apnoea diagnosis Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Sleep apnoea and systemic hypertension Source: Eur Respir Mon 2010; 50: 150-173 Year: 2010 Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011